SCHEMBL8548812

SCHEMBL8548812

CSc1ncccc1C(=O)NCC1CCN(CC2COc3ccc(C)cc3O2)CC1.Cc1ccc2c(c1)OC(CN1CCC(CNC(=O)c3ccc(-n4cccc4)nc3)CC1)CO2

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
ADRA2C P18825 7/20 0.40
ADRA2A P08913 6/20 0.40
ADRA2B P18089 6/20 0.40
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8386793 0.91 ADRA1D (0.44) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL6977999 0.91 ADRA1D (0.44) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL6977939 0.90 ADRA1D (0.49) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL8384761 0.90 ADRA1D (0.49) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL8382610 0.82 NPC1 (0.45) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL8383092 0.82 ADRA1D (0.48) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL6978374 0.82 ADRA1D (0.48) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL8383003 0.82 ADRA1D (0.48) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL8384929 0.82 DRD2 (0.49) ADRA1DADRA1AADRA1BADRA2CADRA2A
SCHEMBL6980394 0.82 NPC1 (0.45) ADRA1DADRA1AADRA1BADRA2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP claimed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO claimed